Budesonide has 90% first-pass hepatic metabolism, and therefore has less systemic absorption beyond the intestinal tract and the liver, reducing the risk of glucocorticoid toxicity with high doses or long-term use
Stanford Max Meradith, senior, Deans List, College of Education and Human Sciences, nutrition and health sciences
This has led to the concept of pathway-specific hepatic insulin resistance, where the insulin activation pathway involving protein kinase B/forkhead box protein O1 is inhibited, while the SREBP-1c pathway remains activated (61)
Useful support usually includes: A clear starting assessment that reviews diagnosis, timeline, and prior taper attempts Dose precision using available formulations and, when needed, compounded medications Close follow-up so problems are addressed early Attention to relapse risk rather than assuming every symptom is withdrawal Therapeutic support for sleep disruption, anxiety, and fear during the process If you're specifically looking for medication reduction support, this page on working with a deprescribing psychiatrist can help you understand what that care model looks like
By bridging computational intelligence with materials science, researchers are moving toward a future where nanomedicine is not only more personalized and predictive but also more robust and translatable across diverse clinical settings
Grande LA, Cundiff D, Greenwald MK, Murray M, Wright TE, Martin SA
